Middle East and Africa Point of Care Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Glucose Monitoring Products, Infectious Disease Testing Products, Cardiometabolic Testing Products, Pregnancy and Fertility Testing Products, Coagulation Testing Products, Tumor/Cancer Marker Testing Products, Cholesterol Testing Products, Urinalysis Testing Products, Hematology Testing Products, and Other POC Products), Prescription Mode (Prescription-Based Testing and OTC Testing), and End User (Professional Diagnostic Centers, Home Care, Research Laboratories, and Others)
Market Introduction
The United Arab Emirates (UAE), Saudi Arabia and South Africa are the major countries in the MEA. The UAE was the largest market for Point of care Diagnostics in this region in 2020. Among the major countries in the MEA, the UAE has witnessed significant growth in the point of care diagnostics industry over the years. The growth of this industry in the UAE is attributed to the increasing in healthcare expenditure, and high prevalence of cancer, diabetes, and other diseases in the UAE. Moreover, the availability of quality healthcare drives market growth. According to the global cancer registry, in 2020, around 4,000 new cases of cancer were diagnosed in the country. ising geriatric population, shift in lifestyle, reduced physical activities, and obesity, among others, are the risk factors that are leading to the rise in the prevalence of diabetes. As per the International Diabetes Federation (IDF) Atlas 2020, the prevalence of diabetes was an estimated 1.22 million in UAE. The disease was observed commonly in the age group of 20–79 years. Therefore, the UAE government plans major actions to bring down the prevalence of diabetes in the region to 16% by 2021 by spreading awareness. Such activities are estimated to drive the demand point of care diagnostics in UAE, thereby driving the MEA point of care diagnostics market.
In case of COVID-19, MEA is highly affected specially Turkey. Economic uncertainties and ongoing conflicts are worsening the condition in the region. For instance, countries such as Syria, Libya, and Yemen are suffering violent conflict and cannot implement any public health measures. Iran was in deep economic recession due to the US sanctions. Also, the major source of economic stabilization in Middle East countries is oil production and export. However, the recent pandemic is causing turbulence to the economies of the Middle East region. A sudden drop in domestic and external demand for goods and products, especially crude oil, and halted production due to labor shortage, are major impacts observed in the region. The Saudi government policies are favored of domestic pharmaceutical manufacturers including not any import duties on raw materials & intermediate products and interest-free funding support the growth of the pharmaceutical market in this region. Similarly, increasing incidence of COVID-19 create huge demand for kits and reagent used in detection of covid-19 virus. In April 2020, BGI Group, a Chinese genomics company, and Group-42, a UAE technology company, unveiled a new massive-throughput laboratory in the UAE to help with testing and diagnosis of the novel coronavirus. According to BGI, the lab will use RT-PCR diagnostic kits that have been approved by medical regulatory authorities in China, Europe, the United States, and Japan. As point of care diagnostics kits are majorly used in detection of novel coronavirus, so there was high impact of covid-19 on the point of care diagnostics market.
Get more information on this report :
Market Overview and Dynamics
The MEA point of care diagnostics market is expected to grow from US$ 2,484.03 million in 2021 to US$ 5,433.77 million by 2028; it is estimated to grow at a CAGR of 11.8% from 2021 to 2028. Escalating product launches and product developments is expected to fuel the market growth. The number of point-of-care testing has steadily increased over the last 40 years since its widespread introduction. The point of care market is likely to grow with the introduction of new products into the market, aimed at delivering inexpensive care at the facilities located at the closest-possible distances from the patients’ location. New technologies or products are being refined and improved to deliver easier to use devices with incremental improvements in analytical performance. The growth of the POC market is mainly attributed to the introduction of new devices to perform molecular testing. Many new devices have been launched in recent years. For instance, in June 2019, Abbott launched first-ever rapid POC HbA1c test to aid in the diagnosis of diabetes; this test provides results in three minutes, enabling clinicians to develop informed, individualized care plans during patient consultation. Moreover, in July 2021, BD announced launch of rapid and portable point-of-care antigen test for diagnosis of COVID-19. The new test kit is capable to deliver results within 15 minutes of the test. Such advancements in new launched devices will propel the overall MEA POC market growth during the forecast period.
Key Market Segments
In terms of product, the glucose monitoring products segment accounted for the largest share of the MEA point of care diagnostics market in 2020. In terms of prescription mode, the prescription-based testing segment held a larger market share of the MEA point of care diagnostics market in 2020. Further, the professional diagnostic centers segment held a larger share of the MEA point of care diagnostics market based on end user in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the MEA point of care diagnostics market are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Abbott; BD; bioMerieux SA; BIO-RAD LABORATORIES INC.; Danaher; F. HOFFMANN-LA ROCHE LTD.; Johnson and Johnson Services, Inc.; Nova Biomedical; Polymer Technology Systems, Inc. (PTS); and Siemens AG.
Reasons to buy report
- To understand the MEA point of care diagnostics market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for MEA point of care diagnostics market
- Efficiently plan M&A and partnership deals in MEA point of care diagnostics market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form MEA point of care diagnostics market
- Obtain market revenue forecast for market by various segments from 2021-2028 in MEA region.
MEA Point of Care Diagnostics Market Segmentation
MEA Point of Care Diagnostics Market - By Product
- Glucose Monitoring Products
- Infectious Disease Testing Products
- HIV Testing
- Influenza Testing
- Sexually Transmitted Disease (STD) Testing
- Hepatitis C Testing
- Healthcare-Associated Infection (HAI) Testing
- Tropical Disease Testing
- Respiratory Infection Testing
- Other Infectious Disease Testing
- Cardiometabolic Testing Products
- Pregnancy and Fertility Testing Products
- Coagulation Testing Products
- Tumor/Cancer Marker Testing Products
- Cholesterol Testing Products
- Urinalysis Testing Products
- Hematology Testing Products
- Other POC Products
MEA Point of Care Diagnostics Market - By Prescription Mode
- Prescription-Based Testing
- OTC Testing
MEA Point of Care Diagnostics Market - By End User
- Professional Diagnostic Centers
- Hospitals
- Clinical Laboratories
- Outpatient Healthcare
- Ambulatory Care Settings
- Home Care
- Research Laboratories
- Others
MEA Point of Care Diagnostics Market - By Country
- UAE
- Saudi Arabia
- South Africa
- Rest of MEA
MEA Point of Care Diagnostics Market - Company Profiles
- Abbott
- BD
- bioMerieux SA
- BIO-RAD LABORATORIES INC.
- Danaher
- F. HOFFMANN-LA ROCHE LTD.
- Johnson and Johnson Services, Inc.
- Nova Biomedical
- Polymer Technology Systems, Inc. (PTS)
- Siemens AG
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 MEA Point of Care Diagnostics Market – By Product
1.3.2 MEA Point of Care Diagnostics Market – By Prescription Mode
1.3.3 MEA Point of Care Diagnostics Market – By End User
1.3.4 MEA Point of Care Diagnostics Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. MEA Point of Care Diagnostics Market – Market Landscape
4.1 Overview
4.2 MEA PEST Analysis
5. MEA Point of Care Diagnostics Market – Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Surging Prevalence of Infectious Diseases
5.1.2 Escalating Product Launches and Product Developments
5.1.3 Mounting Number of CLIA-waived POC tests
5.2 Market Restraints
5.2.1 Rising Product Recalls in Market
5.3 Market Opportunities
5.3.1 Rising Number of Conferences and Events
5.4 Future Trends
5.4.1 Growth in the Use of Home-Based POC Devices
5.5 Impact Analysis
6. Point of Care Diagnostics Market – MEA Analysis
6.1 MEA Point of Care Diagnostics Market Revenue Forecast and Analysis
7. MEA Point of Care Diagnostics Market Analysis– by Product
7.1 Overview
7.2 MEA Point of Care Diagnostics Market, By Product 2020 & 2028 (%)
7.3 Glucose Monitoring
7.3.1 Overview
7.3.2 Glucose Monitoring Market Revenue and Forecasts to 2028 (US$ Mn)
7.4 Infectious Disease Testing
7.4.1 Overview
7.4.2 Infectious Disease Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.3 HIV Testing
7.4.3.1 Overview
7.4.3.2 HIV Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.4 Influenza Testing
7.4.4.1 Overview
7.4.4.2 Influenza Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.5 Sexually Transmitted Disease (STD) Testing
7.4.5.1 Overview
7.4.5.2 Sexually Transmitted Disease (STD) Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.6 Hepatitis C Testing
7.4.6.1 Overview
7.4.6.2 Hepatitis C Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.7 Healthcare-Associated Infection (HAI) Testing
7.4.7.1 Overview
7.4.7.2 Healthcare-Associated Infection (HAI) Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.8 Tropical Disease Testing
7.4.8.1 Overview
7.4.8.2 Tropical Disease Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.9 Respiratory Infection Testing
7.4.9.1 Overview
7.4.9.2 Respiratory Infection Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.10 Other Infectious Disease
7.4.10.1 Overview
7.4.10.2 Others Infection Disease Market Revenue and Forecasts to 2028 (US$ Mn)
7.5 Cardiometabolic Testing
7.5.1 Overview
7.5.2 Cardiometabolic Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.6 Pregnancy and Fertility Testing
7.6.1 Overview
7.6.2 Pregnancy and Fertility Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.7 Coagulation Testing
7.7.1 Overview
7.7.2 Coagulation Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.8 Tumor/Cancer Marker Testing
7.8.1 Overview
7.8.2 Tumor/Cancer Marker Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.9 Cholesterol Testing
7.9.1 Overview
7.9.2 Cholesterol Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.10 Urinalysis Testing
7.10.1 Overview
7.10.2 Urinalysis Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.11 Haematology Testing
7.11.1 Overview
7.11.2 Haematology Testing Revenue and Forecasts to 2028 (US$ Mn)
7.12 Other POC
7.12.1 Overview
7.12.2 Other POC Market Revenue and Forecasts to 2028 (US$ Mn)
8. MEA Point of Care Diagnostics Market Analysis– by Prescription Mode
8.1 Overview
8.2 MEA Point of Care Diagnostics Market, By Prescription Mode 2020 & 2028 (%)
8.3 Prescription-Based Testing Market
8.3.1 Overview
8.3.2 Prescription-Based Testing Market Revenue and Forecasts to 2028 (US$ Mn)
8.4 OTC Testing Market
8.4.1 Overview
8.4.2 OTC Testing Market Revenue and Forecasts to 2028 (US$ Mn)
9. MEA Point of Care Diagnostics Market Analysis– by End User
9.1 Overview
9.2 MEA Point of Care Diagnostics Market, By End User 2020 & 2028 (%)
9.3 Professional Diagnostic Centers
9.3.1 Overview
9.3.2 Professional Diagnostic Centers Market Revenue and Forecasts to 2028 (US$ Mn)
9.3.3 Hospitals
9.3.3.1 Overview
9.3.3.2 Hospitals Market Revenue and Forecasts to 2028 (US$ Mn)
9.3.4 Clinical Laboratories
9.3.4.1 Overview
9.3.4.2 Clinical Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)
9.3.5 Outpatient Healthcare
9.3.5.1 Overview
9.3.5.2 Outpatient Healthcare Market Revenue and Forecasts to 2028 (US$ Mn)
9.3.6 Ambulatory Care Settings
9.3.6.1 Overview
9.3.6.2 Ambulatory Care Settings Market Revenue and Forecasts to 2028 (US$ Mn)
9.4 Home Care
9.4.1 Overview
9.4.2 Home Care Market Revenue and Forecasts to 2028 (US$ Mn)
9.5 Research Laboratories
9.5.1 Overview
9.5.2 Research Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)
9.6 Others
9.6.1 Overview
9.6.2 Others Market Revenue and Forecasts to 2028 (US$ Mn)
10. MEA Point of Care Diagnostics Market – Country Analysis
10.1 MEA: Point of care Diagnostics Market
10.1.1 Overview
10.1.2 MEA: Point of Care Diagnostics Market, By Country, 2020 & 2028 (%)
10.1.3 UAE: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.3.1 UAE: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.3.2 UAE: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
10.1.3.2.1 UAE: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
10.1.3.3 UAE: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
10.1.3.4 UAE: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
10.1.3.4.1 UAE: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
10.1.4 Saudi Arabia: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.4.1 Saudi Arabia: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.4.2 Saudi Arabia: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
10.1.4.2.1 Saudi Arabia: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
10.1.4.3 Saudi Arabia: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
10.1.4.4 Saudi Arabia: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
10.1.4.4.1 Saudi Arabia: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
10.1.5 South Africa: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.5.1 South Africa: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.5.2 South Africa: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
10.1.5.2.1 South Africa: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
10.1.5.3 South Africa: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
10.1.5.4 South Africa: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
10.1.5.4.1 South Africa: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
10.1.6 Rest of MEA: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.6.1 Rest of MEA: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.6.2 Rest of MEA: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
10.1.6.2.1 Rest of MEA: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
10.1.6.3 Rest of MEA: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
10.1.6.4 Rest of MEA: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
10.1.6.4.1 Rest of MEA: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
11. Impact of COVID-19 Pandemic on MEA Point of Care Diagnostics Market
11.1 MEA: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Organic Growth Strategies
12.2.1 Overview
12.3 Inorganic Growth Strategies
12.3.1 Overview
13. Company Profiles
13.1 F. HOFFMANN-LA ROCHE LTD.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Danaher
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 BIO-RAD LABORATORIES INC.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Abbott
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Johnson and Johnson Services, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Siemens AG
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 BD
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 bioMerieux SA
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4
13.8.5 Financial Overview
13.8.6 SWOT Analysis
13.8.7 Key Developments
13.9 Polymer Technology Systems, Inc. (PTS)
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Nova Biomedical
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. MEA Point of Care Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Table 2. UAE: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 3. UAE: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 4. UAE: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 5. UAE: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 6. UAE: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)
Table 7. Saudi Arabia: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 8. Saudi Arabia: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 9. Saudi Arabia: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 10. Saudi Arabia: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 11. Saudi Arabia: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)
Table 12. South Africa: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 13. South Africa: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 14. South Africa: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 15. South Africa: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 16. South Africa: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)
Table 17. Rest of MEA: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 18. Rest of MEA: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 19. Rest of MEA: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 20. Rest of MEA: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 21. Rest of MEA: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)
Table 22. Recent Organic Developments the Point of Care Diagnostics Market
Table 23. Recent Inorganic Developments in the Point of Care Diagnostics Market
Table 24. Glossary of Terms
LIST OF FIGURES
Figure 1. MEA Point of Care Diagnostics Market Segmentation
Figure 2. MEA Point of Care Diagnostics Market Segmentation, By Country
Figure 3. MEA Point of Care Diagnostics Market Overview
Figure 4. Prescription-Based Testing Segment Held Largest Share of MEA Point of Care Diagnostics Market
Figure 5. UAE to Show Significant Growth During Forecast Period
Figure 6. MEA: PEST Analysis
Figure 7. Impact Analysis of Driver and Restraints Pertaining to MEA Point of Care Diagnostics Market
Figure 8. MEA Point of Care Diagnostics Market – Revenue Forecast and Analysis
Figure 9. MEA Point of Care Diagnostics Market, by Products 2020 & 2028 (%)
Figure 10. MEA Glucose Monitoring Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 11. MEA Infectious Disease Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. MEA HIV Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 13. MEA Influenza Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 14. MEA Sexually Transmitted Disease (STD) Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 15. MEA Hepatitis C Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 16. MEA Healthcare-Associated Infection (HAI) Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17. MEA Tropical Disease Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 18. MEA Respiratory Infection Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 19. MEA Others Infection Disease Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 20. MEA Cardiometabolic Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 21. MEA Pregnancy and Fertility Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 22. MEA Coagulation Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 23. MEA Tumor/Cancer Marker Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 24. MEA Cholesterol Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 25. MEA Urinalysis Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 26. MEA Haematology Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 27. MEA Other POC Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 28. MEA Point of Care Diagnostics Market, by Prescription Mode 2020 & 2028 (%)
Figure 29. MEA Prescription-Based Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 30. MEA OTC Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 31. MEA Point of Care Diagnostics Market, by End User 2020 & 2028 (%)
Figure 32. MEA Professional Diagnostic Centers Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 33. MEA Hospitals Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 34. MEA Clinical Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 35. MEA Outpatient Healthcare Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 36. MEA Ambulatory Care Settings Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 37. MEA Home Care Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 38. MEA Research Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 39. MEA Others Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 40. MEA: Point of Care Diagnostics Market, by Key Country- Revenue (2020) (USD Million)
Figure 41. MEA: Point of Care Diagnostics Market, By Country, 2020 & 2028 (%)
Figure 42. UAE: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 43. Saudi Arabia: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 44. South Africa: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 45. Rest of MEA: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 46. Impact of COVID-19 Pandemic in MEA Country Markets
- Abbott
- BD
- bioMerieux SA
- BIO-RAD LABORATORIES INC.
- Danaher
- F. HOFFMANN-LA ROCHE LTD.
- Johnson and Johnson Services, Inc.
- Nova Biomedical
- Polymer Technology Systems, Inc. (PTS)
- Siemens AG
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the MEA point of care diagnostics market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in MEA point of care diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth MEA market trends and outlook coupled with the factors driving the point of care diagnostics market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution